Policy & Regulation
Vault Pharma Launches Coronavirus Vaccine Development
2 June 2020 - - US-based emerging company developing biotechnology invented at UCLA is adapting their approach to address the novel coronavirus, with the goal of adding to the anti-COVID-19 arsenal th...
Eisai unveils DAYVIGO (lemborexant) CIV for the US insomnia market
2 June 2020 - Pharmaceutical company Eisai Inc reported on Monday the launch of the US FDA approved DAYVIGO (lemborexant) CIV for the treatment of adults with insomnia, characterised by difficulties w...
Camurus files request for final approval of Brixadi with the FDA for the treatment of opioid use disorder
2 June 2020 - Swedish biopharmaceutical company Camurus AB (NASDAQ:CAMX) (STO:CAMX) announced on Monday that it has filed a request for final approval of Brixadi (buprenorphine) with the US Food and D...
PTC Therapeutics completes Censa Pharmaceuticals acquisition
2 June 2020 - PTC Therapeutics Inc (NASDAQ: PTCT), a science-driven, global biopharmaceutical company, has completed the acquisition of Censa Pharmaceuticals Inc, a biopharmaceutical company concentra...
Proteostasis Therapeutics reveals results from in vitro studies of COVID-19 treatment PTI-129
2 June 2020 - Proteostasis Therapeutics Inc (Nasdaq:PTI), a clinical stage biopharmaceutical company, has revealed results from in vitro studies assessing the use of PTI-129 intended for the treatment...
Eli Lilly doses patients in first study of COVID-19 Antibody Treatment LY-CoV555
2 June 2020 - Eli Lilly and Company (NYSE: LLY), a global healthcare company, has dosed patients in the first study of LY-CoV555 intended to prevent COVID-19, it was reported on Monday.The product has...
Related Headlines

Twist Bioscience to Join Proteona in Global Alliance to Protect Immunocompromised Patients From COVID-19 Infection

LabCorp Launches New COVID-19 Clinical Trial Site to Connect Patients with US Research Trials

FDA Accepts Shionogi's Supplemental New Drug Application with Priority Review for Fetroja for the Treatment of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID-19 Patients with Right Heart Failure

Codiak BioSciences Collaborates with Ragon Institute to Evaluate the exoVACC Vaccine Platform in SARS-CoV-2 and HIV

Hansa Biopharma names new CMO

Tangen Biosciences, LabWare Form Exclusive Partnership for Point-of-Care COVID-19 Molecular Test and Real-time Data Reporting

Lightship Market Research Confirms Patients' Interest in Direct-to-Patient Trial offering Amidst COVID-19 Pandemic

Beckman Coulter Life Sciences' RNA extraction kit ready for use in EUA authorized COVID-19 test

Genentech Starts Phase III Clinical Trial of Actemra Plus Remdesivir in Hospitalized Patients with Severe COVID-19 Pneumonia

Virna Therapeutics Teams with University of Toronto on Licensing of Neutralizing Monoclonal Antibodies to Treat COVID-19

StemExpress Expands offering of COVID-19 Testing to Skilled Nursing Facilities

PureTech Advances LYT-100 for Treatment of Serious Respiratory Complications that Persist Following Resolution of COVID-19 Infection

ImmunityBio, NantKwest Ink COVID-19 Joint Development, Manufacturing and Marketing Agreement

Pneumagen commits GBP4m for clinical trial development for COVID-19